参考文献

［1］Lai EC，Lau WY. Aggressive surgical resection for carcinoma of gallbladder［J］.ANZ J Surg，2005 Jun；75（6）：441-444.

［2］Fong Y，Jarnagin W，Blumgart LH.Gallbladder cancer：comparison of patients presenting initially for definitive operation with those presenting after prior noncurative intervention［J］.Ann Surg，2000 Oct；232（4）：557-569.

［3］Tsukada K，Hatakeyama K，Kurosaki I，et al.Outcome of radical surgery for carcinoma of the gallbladder according to the TNM stage［J］.Surgery，1996 Nov；120（5）：816-821.

［4］Donohue JH. Present status of the diagnosis and treatment of gallbladder carcinoma［J］.J Hepatobifiary Pancreat Surg，2001，8（6）：530-534.

［5］Fujita N，Noda Y，Kobayashi G，et al.Diagnosis of the depth of invasion of gallbladder caroinoma by EUS［J］.Gastrointest Endose，1999，50（5）：659，663.

［6］Hiroki Kawashima，Yoshiki Hirooka，Akihiro Itoh，et al.Use of color Doppler ultrasonography in the diagnosis of anomalous connection in pancreatobiliary disease［J］.World J Gastroenterol，2005，11（7）：1018-1022.(https://www.daowen.com)

［7］Shira Z，Tsukada K，Ohtani Z，et al. Hepatic metastases from carcinoma of the gallbladder［J］.Cancer，1995，75（8）：2063.

［8］Kaushik SV，Current perspectives in gallbladder carcinoma［J］.J Gastroenterol Hepatol，2001，16（8）：848-854.

［9］Pradeep IT，Kaushik SV，Sikora SS，et al.Predictors of survival in carcinoma of the gallbladder［J］.Cancer，1995，76（7）：1145-1149.

［10］Valle JW，Wasan HS，Palmer DH，et al.Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer［J］.N Eng J Med，2010，362（14）：1273-1281.

［11］Lamarca A，Palmer DH，Wasan HS，et al.A randomised phaseⅢ，multi-centre，open-label study of active symptom control（ASC）alone or ASC with oxaliplatin／5-FU chemotherapy（ASC+mFOLFOX）for patients with locally advanced／metastatic biliary tract cancers（ABC）previously-treated with cisplatin／gemcitabine（Cis／Gem）chemotherapy［J］.J Clin Oncol 2019，37（Suppl 15）：4003.